# Data Integrity and Compliance With Drug Current Good Manufacturing Process: Questions and Answers; Guidance for Industry; Availability; Correction
**AGENCY:**
Food and Drug Administration, HHS
**ACTION:**
Notice; correction.
**SUMMARY:**
The Food and Drug Administration is correcting a notice entitled “Data Integrity and Compliance With Drug CGMP: Questions and Answers; Guidance for Industry; Availability” that appeared in the *Federal Register* of December 13, 2018. The document announced the availability of a guidance for industry. The document was published with the incorrect docket number. This document corrects that error. Previously submitted comments will be transferred to the correct docket number.
**FOR FURTHER INFORMATION CONTACT:**
Karen Takahashi, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 75, Rm. 6686, Silver Spring, MD 20993-0002, 301-796-3191.
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of Thursday, December 13, 2018 (83 FR 64132), in FR Doc. 2018-26957, the following correction is made:
On page 64132, in the first column, in the header of the document, “[Docket No. FDA-2018-D-3984]” is corrected to read “[Docket No. FDA-2016-D-1113].”
Dated: March 6, 2019.
Lowell J. Schiller,
Acting Associate Commissioner for Policy.